A new FDA target action date of 28 December could bring tolebrutinib’s tumultuous development period to an end.

The U.S. Food and Drug Administration is delaying by three months its decision on whether or not to approve tolebrutinib for ...

Northeastern governors, like their peers in the West, want to shore up public health and issue a stamp of approval for ...

A massive, billion-dollar settlement over a copyright class action suit brought by a group of authors against a San Francisco ...

BlinkOps has entered an exclusive partnership with Microsoft, bringing agentic security automation natively to Microsoft ...

A generic formulation of Zeposia will be manufactured and supplied by Netherlands-based Synthon, upon final approval by the ...

Instagram has reached 3 billion monthly users, cementing the network as one of the most popular consumer apps of all time and ...

But despite having bipartisan support and a stamp of approval from Bernie Sanders (I-Vt.)—who has long argued H-1B visas ...

Microsoft’s Fairwater AI supercomputer will house hundreds of thousands of GPUs and deliver 10x the power of today’s fastest ...

Tentative deal clears a path for OpenAI’s restructuring Software King of the World, Microsoft and ChatGPT maker OpenAI have agreed to extend their partnership in a move that could smooth the startup’s ...

Australia's biggest gas project, Woodside's North West Shelf, has received final approval to extend operations through until ...

Elon Musk, Satya Nadella, and other tech leaders held an H-1B visa earlier in their careers. The program is set for big ...